<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Koch Chaves, H.</style></author><author><style face="normal" font="default" size="100%">de Freitas da Silveira, C. C.</style></author><author><style face="normal" font="default" size="100%">de Souza Antunes, A. M.</style></author><author><style face="normal" font="default" size="100%">Lima de Magalhães, J.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">AN OVERVIEW OF SCIENTIFIC PRODUCTION ON INJECTABLE ANTINEOPLASTICS IN THE WEB OF SCIENCE DATABASE AS A CONTRIBUTION TO PUBLIC HEALTH MANAGEMENT</style></title><secondary-title><style face="normal" font="default" size="100%">Problems of Management in the 21st Century</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">bibliometric analysis</style></keyword><keyword><style  face="normal" font="default" size="100%">cancer</style></keyword><keyword><style  face="normal" font="default" size="100%">co-citation</style></keyword><keyword><style  face="normal" font="default" size="100%">injectable antineoplastics</style></keyword><keyword><style  face="normal" font="default" size="100%">public health</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December/2023</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://oaji.net/articles/2023/450-1705396590.pdf</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">18</style></volume><pages><style face="normal" font="default" size="100%">Continuous</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">According to data from the United Nations, cancer is the second leading cause of death in the world. Studies in the area advocate that this data be treated in an agile manner, to extract essential information. This work analyzed the characteristics of the world's scientific production on injectable oncologic agents present in articles in the Web of Science database between 2001 and 2021. Bibliometrics were performed on 1,496 articles. There was a constant increase in publications over the years – emphasis on 2021. The technological domain “pharmacy and pharmacology” was the most recurrent. China is the leader with a total of 505, while Elsevier was the publisher of the most published articles in the analyzed period. In relation to the most productive authors, Qian ZY stands out, with 18 articles. The most productive institution is the Chinese Academy of Sciences with 68 articles. Concerning networks using VOSviewer®, the following stand out: Li, Y. et al. (2012), (co-citation of references; 62); “Biomaterials” (co-citation of journals; 3,006); nanoparticles (keyword co-occurrence; 262); Soo-Chang Song (bibliographic coupling; 776). The study helps public health stakeholders in injectable antineoplastics to obtain essential information and thus contribute to better health management in both the public and private sectors.</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original article</style></work-type><section><style face="normal" font="default" size="100%">21-33</style></section></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jorge Magalhães</style></author><author><style face="normal" font="default" size="100%">Koch Chaves, H.</style></author><author><style face="normal" font="default" size="100%">Viviane Theodora Muniz</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">AN OVERVIEW OF BIG DATA IN COVID-19 AS A CONTRIBUTION TO THE MANAGEMENT OF SCIENTIFIC AND TECHNOLOGICAL KNOWLEDGE</style></title><secondary-title><style face="normal" font="default" size="100%">Problems of Management in the 21st Century</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Big Data</style></keyword><keyword><style  face="normal" font="default" size="100%">coronavirus patents</style></keyword><keyword><style  face="normal" font="default" size="100%">Covid-19</style></keyword><keyword><style  face="normal" font="default" size="100%">knowledge management</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December/2021</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://oaji.net/articles/2021/450-1640180701.pdf</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">Continuous</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">In times of pandemic, rapid sharing of research data is urgently needed, as is the intensification of networking. The COVID-19 pandemic brought a new perspective in relation to knowledge management in various organizational means, whether through the search for innovation or the improvement of its processes. Thus, to calculate the state of the art and track scientific and technological knowledge in the COVID-19 spectrum, the keyword “Coronavir*” was used in the PubMed and Espacenet databases. Data were processed by Carrot Search Lingo4G® and PatentInspiration®. In the Pubmed database, 1,000 documents were retrieved, which were organized into 81 groups of sub-themes, with emphasis on the sub-theme “treatment during coronavirus disease”, with 188 articles (18.8% of the total). Regarding technological innovation, China and the United States were the countries that filed the most patent applications, especially in 2020 and 2021, corresponding to 68.5% of the total. The first 4 (four) applicants with the highest number of patents were Pfizer, Gilead Sciences Inc., Center Nat Rech, Crucell Holland. The results obtained over a period of time demonstrate a partnership between universities and companies towards the fight against the pandemic. The tools for identifying, extracting and processing data (or free), are needed efficiently in the management of scientific and technological knowledge in COVID -19, thus being able to contribute to more assertive decision-making at various organizational levels.</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original article</style></work-type><section><style face="normal" font="default" size="100%">102-111</style></section></record></records></xml>